Charles Ornstein, ProPublica

Prominent Doctors Aren’t Disclosing Their Industry Ties in Medical Journal Studies. And Journals Are Doing Little to Enforce Their Rules

The dean of Yale’s medical school, the incoming president of a prominent cancer group and the head of a Texas cancer center are among leading medical figures who have not accurately disclosed their relationships with drug companies.

• By Charles Ornstein, ProPublica and Katie Thomas, The New York Times
• Tags: National

The Supreme Court Upheld Trump's Travel Ban; Here's How ProPublica Reported How it Wreaks Havoc on Families

The executive order separates families who made every effort to follow U.S. immigration law.

• By Charles Ornstein, ProPublica, Marcelo Rochabrun, ProPublica, and Terry Parris Jr., ProPublica
• Tags: National

Take the Generic Drug, Patients Are Told - Unless Insurers Say No

Faced with competition, some pharmaceutical companies are cutting deals with insurance companies to favor their brand-name products over cheaper generics. Insurers pay less, but sometimes consumers pay more.

• By Charles Ornstein, ProPublica and Katie Thomas, The New York Times
• Tags: National

Report: 'Extreme' Use of Painkillers and Doctor Shopping Plague Medicare

Some Medicare beneficiaries are being prescribed opioids by 10 or more doctors, or are filling prescriptions for more than 1,000 pills a month. Hundreds of doctors appear to be prescribing indiscriminately.

• By Charles Ornstein, ProPublica
• Tags: National

Trump's Not the Only One Blocking Constituents on Twitter

Some say it violates the First Amendment. Legislators say it’s about promoting a “healthy, civil dialogue.” Expect court battles ahead.

• By Charles Ornstein, ProPublica
• Tags: National

A Drug Quintupled in Price. Now, Drug Industry Players Feud Over the Windfall

Amid public concern over spiking drug prices, a powerful middleman is suing a tiny drugmaker over unpaid rebates and fees. The maker calls the suit baseless; analysts say the suit offers a window into an opaque world.

• By Charles Ornstein, ProPublica and Katie Thomas, The New York Times
• Tags: National

Three Strategies to Defend the GOP Health Bill: Euphemisms, False Statements and Deleted Comments

Since the passage of the American Health Care Act, Republican members of Congress have tried to swing public opinion to their side. ProPublica has been tracking what they’re saying.

• By Charles Ornstein, ProPublica
• Tags: National

On Health Reform, Democrats and Republicans Don't Speak the Same Language

We analyzed more than 575 press releases from representatives and senators about the Affordable Care Act and its repeal. Democrats, we found, speak more often and are more united.

• By Charles Ornstein, ProPublica and Derek Willis, ProPublica
• Tags: National

We Fact-Checked Lawmakers' Letters to Constituents on Health Care

They’re full of lies and misinformation

• By Charles Ornstein, ProPublica
• Tags: National

Fact-Checking Elected Officials on the Affordable Care Act Repeal

ProPublica is working with other news organizations to collect and analyze letters and emails from elected officials to constituents on the ACA, beginning with a misleading missive by Missouri Sen. Roy Blunt.

• By Charles Ornstein, ProPublica
• Tags: National

Trump's Travel Ban is Wreaking Havoc on Families, Especially Those With Valid Visas

• By Charles Ornstein, ProPublica, Terry Parris Jr., ProPublica, and Marcello Rochabrun, ProPublica
The executive order banning travel from seven predominantly Muslim nations is separating families who made every effort to follow U.S. immigration law.
• Tags: National